/Companies

ACT Genomics Holdings Company Ltd.

2 known investors

Find your way into ACT Genomics Holdings Company Ltd.

Sign up to see every warm intro you have to ACT Genomics Holdings Company Ltd.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ACT Genomics Holdings Company Ltd. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.

Investors · 2

Related companies · 6

Companies working in the same space as ACT Genomics Holdings Company Ltd..

Frequently asked questions

What does ACT Genomics Holdings Company Ltd. do?
ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.
Who are ACT Genomics Holdings Company Ltd.'s investors?
ACT Genomics Holdings Company Ltd.'s investors include Kyoto University Innovation Capital, UMC Capital.